2010
DOI: 10.1016/j.pupt.2009.09.003
|View full text |Cite
|
Sign up to set email alerts
|

Apocynin decreases hydrogen peroxide and nirtate concentrations in exhaled breath in healthy subjects

Abstract: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. M A N U S C R I P T A C C E P T E D ARTICLE IN PR… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

2
22
0

Year Published

2010
2010
2019
2019

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 32 publications
(24 citation statements)
references
References 57 publications
(66 reference statements)
2
22
0
Order By: Relevance
“…However, in vivo, a metabolite of this compound may act as a true NOX inhibitor, and it may show some specificity for NOX2. We and others have shown that nebulized apocynin is safe (142), prevented ozone-induced exacerbations of asthma, and decreased selected ROS and RNS in mild asthmatics and patients with COPD (117, 140, 141). Therefore, even the nonselective ROS-scavenging and NOXmodifying strategy might be beneficial in inflammatory airway disorders and deserves further clinical studies in clearly defined populations and with the reasonable caution of the possible adverse effects and cytotoxicity.…”
Section: Small-molecule Inhibitorsmentioning
confidence: 86%
“…However, in vivo, a metabolite of this compound may act as a true NOX inhibitor, and it may show some specificity for NOX2. We and others have shown that nebulized apocynin is safe (142), prevented ozone-induced exacerbations of asthma, and decreased selected ROS and RNS in mild asthmatics and patients with COPD (117, 140, 141). Therefore, even the nonselective ROS-scavenging and NOXmodifying strategy might be beneficial in inflammatory airway disorders and deserves further clinical studies in clearly defined populations and with the reasonable caution of the possible adverse effects and cytotoxicity.…”
Section: Small-molecule Inhibitorsmentioning
confidence: 86%
“…Subjects were asked to breathe at a normal frequency and tidal volume through a mouthpiece connected to a condenser for 20 minutes. The use of a nose clip during the collection of EBC was important (1) to prevent air inhalation through the nose (biomarker aerosols from the nasal epithelium might enter the inhaled air); (2) to prevent leakage from the lower airways through the nose; and (3) to prevent mixing of nasal and bronchial air [8,22], and finally (4) [17]. A nebulizer Pulmo Aide AP-50 (DeVilbiss, Richmond, VA) was used (mass median aerosol diameter 3.1 µm, output 0.3 mL/min) [17].…”
Section: Exhaled Breath Condensate (Ebc) Collectionmentioning
confidence: 99%
“…Moreover, there were no significant changes in blood pressure, heart rate value, and coughing scale before and after apocynin or placebo application (P > .05). Inhalation of apocynin or placebo aerosol did not have any effect on respiratory parameters [FEV 1 …”
Section: Hematology Lung Function and Cardiovascular Measuresmentioning
confidence: 99%
See 2 more Smart Citations